+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bioinformatics: Technologies and Global Markets

  • ID: 4856627
  • Report
  • November 2019
  • Region: Global
  • 231 Pages
  • BCC Research
1 of 5

FEATURED COMPANIES

  • 3rd Millennium Inc.
  • Dassault Systemes Biovia
  • Genomatix Software Gmbh
  • Illumina Inc.
  • Nonlinear Dynamics Ltd.
  • Qlucore Ab
  • MORE

Report Scope:

The scope of the study encompasses the global bioinformatics market based on geography, category, and application. It provides a detailed analysis of recent advances in omic technologies and examines their impact on the bioinformatics market. It discusses the ways in which bioinformatics has been utilized by the pharma and biotech industries to streamline the research and development (R&D) process and improve efficiencies. It provides a detailed analysis of the leading countries, companies, and technologies that will drive the field forward.

The Report Includes:

  • 31 data tables and 80 additional tables
  • Comprehensive details of the global bioinformatics market and relevant technologies
  • Analyses of global market trends with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Assessment of the market trends and analysis regarding industry service providers and software solution developers, as well as information technology (IT) and bioinformatics service providers that support the pharma and biotech industries
  • Review of challenges and opportunities underlying in the bioinformatics market following the adoption of high-throughput technologies such as next-generation sequencing (NGS), the analysis of big data, and the emergence of cloud-based solutions
  • Insight into the sequencing and pharmaceutical R&D applications of bioinformatics in drug development and clinical trials, including cheminformatics, next-generation sequencing, metagenomics and data management systems
  • A look at the investigational new drug applications, NDA approvals, leading EHRs providers, mobile health technologies, and recent partnerships and agreements in the pharmaceutical and bioinformatic sectors
  • Profile description of key pharmaceutical and biotechnology companies, including Dassault Systemes Biovia, Genedata AG, PerkinElmer Informatics Inc., Qlucore AB, and Syngene International
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3rd Millennium Inc.
  • Dassault Systemes Biovia
  • Genomatix Software Gmbh
  • Illumina Inc.
  • Nonlinear Dynamics Ltd.
  • Qlucore Ab
  • MORE

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Intended Audience
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Global Bioinformatics Market: Overview

  • Goal of Bioinformatics
  • Biological Data Sources
  • Bioinformatics in Systems Biology
  • Precision Medicine
  • Bioinformatics in Drug Development
  • Cheminformatics
  • Next-Generation Sequencing
  • Metagenomics
  • Database Management Systems
  • Market Trends
  • Precision Medicine and Biomarker Identification
  • Cloud-Based Solutions
  • Shift Toward Value-Based Care
  • Market Challenges
  • Data Integration
  • Data Reliability and Standardization
  • End-to-End Workflows
  • Current Market
  • Market by Region
  • Market by Category
  • Public Funding
  • Private Funding
  • Market by Application

Chapter 4 Bioinformatics: Data Generation and Data Management

  • Information Overload
  • Data Volume
  • Data Variety
  • Data Velocity
  • Data Veracity
  • Software Scalability and Validity
  • Technologies Behind Big Data Generation
  • Genomics
  • Exponential Growth in NGS Software Tools
  • Functional Genomics
  • CRISPR Cas9 System
  • Proteomic Advances
  • Qualitative Proteomics
  • Quantitative Proteomics
  • Structural Proteomics
  • Advances in MS-Based Proteomics Technology for Exploring Triple-Negative Breast Cancer
  • Sample Preparation Assays
  • Tagging/Affinity Methods
  • Utility of Proteomics to Identify Biomarkers
  • Investments in Structural Genomics and Open Science
  • Interaction Proteomics
  • Applications in Drug Discovery
  • Bottom-Up vs. Top-Down Proteomics
  • Emergence of Glycomics
  • Human Proteome Organization and Human Proteome Project Initiatives
  • Transcriptomic Advances
  • RNA Sequencing
  • Co-Expression and Single-Cell RNA-Seq
  • Metabolomic Advances
  • Advances in Cheminformatics
  • Emerging Technologies
  • Metagenomic Advances
  • Epigenomic Advances
  • Pharmacogenomic Advances
  • Pharmacogenomics and Precision Medicine
  • Value-Based Decisions
  • Pharmacogenomics and R&D
  • International Serious Adverse Events Consortium
  • Pharmacogenomic Software
  • Toxicogenomic Advances
  • Customized Toxicogenomic Platforms
  • Database Management Services
  • Market Dynamics

Chapter 5 Bioinformatics: Data Analysis and Software

  • Introduction
  • Data Analysis Software
  • Biosimulation Models
  • Market Analysis

Chapter 6 Bioinformatics: Data Processing and Storage

  • Mind the Gap
  • Information Technology Infrastructure
  • High-Performance Computing
  • High-Performance Computer Clusters
  • Cloud Computing
  • Data as a Service
  • Infrastructure as a Service
  • Platform as a Service
  • Software as a Service
  • Security as a Service
  • Cloud Computing Challenges
  • Future of Cloud Computing
  • Market Analysis

Chapter 7 Bioinformatics: Sequencing Services and Platforms

  • Market Analysis
  • Comparative Analysis Across Market Segments, 2017 and 2023
  • Sequencing Services
  • Sequencing Platforms
  • Sequence Analysis Platforms
  • Sequence Alignment Platforms
  • Sequence Manipulation Platforms

Chapter 8 Bioinformatics: Sequencing Applications

  • Market Analysis
  • Agrigenomics
  • Clinical and Medical
  • Genealogy
  • Other Fields

Chapter 9 Bioinformatics Applications in Pharmaceutical R&D

  • Introduction
  • Drug Discovery and Development Process
  • Target Identification
  • Target Validation
  • Lead Identification
  • Lead Optimization
  • Clinical Research: Drug Development
  • Preclinical Experiments
  • Investigational New Drug Applications
  • Clinical Trials
  • New Drug Application
  • NDA Approval
  • Post-Launch Ongoing Studies and Phase IV Clinical Trials
  • Electronic Health Records
  • Mobile Health Technologies
  • Recent Pharmaceutical and Bioinformatics Alliances and Partnerships
  • Conclusions

Chapter 10 Market Trends and Analysis

  • North America
  • United States
  • Canada
  • Europe
  • United Kingdom
  • Germany
  • Switzerland
  • Asia-Pacific
  • India
  • China
  • Conclusions

Chapter 11 Company Profiles

  • 3rd Millennium Inc.
  • Biomatters Ltd. Geneious
  • Compugen Ltd.
  • Dassault Systemes Biovia
  • Dnastar, Inc.
  • Genedata Ag
  • Geneva Bioformatics (Genebio) Sa
  • Genologics Lifesciences Software Inc.
  • Genomatix Software Gmbh
  • GNS Healthcare Inc.
  • GVK Biosciences Pvt. Ltd.
  • Inte Ligand Software Entwicklungs Und Consulting Gmbh
  • Illumina Inc.
  • Macvector Inc.
  • Molecular Connections Pvt. Ltd.
  • Molecular Networks Gmbh
  • Nonlinear Dynamics Ltd.
  • Ocimum Biosolutions Ltd.
  • Perkinelmer Informatics Inc.
  • Personalis Inc.
  • Qlucore Ab
  • Real Time Genomics Inc.
  • Smartgene Services Sarl
  • Strand Life Sciences
  • Syngene International

List of Tables
Summary Table: Overall Global Bioinformatics Market, by Region, Through 2023
Table 1: Investments in Microbiology
Table 2: PDB Data Distribution, by Experimental Method and Molecular Type, 2017
Table 3: RefSeq Accession Growth, 2016 and 2018
Table 4: Sequencing Services and Platforms as Available in EBI Database
Table 5: Recommendations for NGS Bioinformatics Tools
Table 6: Leading Institutional Developers of Bioinformatics Tools, 2017
Table 7: Bioinformatics Tools Used for Metagenomics Analysis
Table 8: DBMS Platforms in Bioinformatics
Table 9: Growth in Selected EMBL-EBI Resources, 2015-2016
Table 10: Number of FDA and EMA Drug Approvals, 2012-2016
Table 11: Global Bioinformatics Market, by Region, Through 2023
Table 12: Public Funding Programs, 2012-2018
Table 13: Global Bioinformatics Market, by Category, Through 2023
Table 14: Global Bioinformatics Market, by Application, Through 2023
Table 15: Cloud-Based Bioinformatics Tools
Table 16: Commercially Available Metabolomics Software
Table 17: Open Access Tools for Complex Liquid Chromatography-Mass Spectrometry Data Analysis
Table 18: Cheminformatics Software Solutions for Drug R&D
Table 19: Bioinformatic Tools for Metagenomic Studies
Table 20: Pharmacogenomic Biomarkers in Drug Labeling
Table 21: Recent Research on Biomarkers
Table 22: Bioinformatic Tools and Databases Used in Pharmacogenomics
Table 23: Bioinformatic Tools for Pharmacogenomic Studies
Table 24: Bioinformatic Tools for Pharmacogenomic Software
Table 25: Toxicogenomic Studies Planned or Ongoing, 2016
Table 26: Bioinformatics Archival Databases
Table 27: Bioinformatics Curative Databases
Table 28: Commercially Available Bioinformatics Databases
Table 29: Biological Databases for Human Research
Table 30: Software for Biological Analysis
Table 31: Open Source Bioinformatics Software
Table 32: NGS Platforms for Clinical Diagnostics
Table 33: Commonly Used Tools for NGS-based DNA Analysis, by Functional Category
Table 34: Commercially Available Integrated DNA Analysis Solutions and Relevant Functionality
Table 35: High-Performance Computing Architectures: Advantages and Drawbacks
Table 36: Highest Performance Supercomputers, 2018
Table 37: SaaS Products
Table 38: Global Bioinformatics Market, by Sequencing Services and Platforms, Through 2023
Table 39: Sequence Analysis Software
Table 40: Sequence Alignment Platforms
Table 41: Global Bioinformatics Market, by Sequencing Application, Through 2023
Table 42: Sequencing Data Analysis Bioinformatics Software and Tools
Table 43: Bioinformatics-Based Clinical and Medical Laboratory Information Management System
Table 44: Number of Therapeutic Drugs Developed Globally, by Disease Category, 2017
Table 45: Bioinformatics Databases
Table 46: Leading Drug Target Databases
Table 47: Computer Simulation Platforms
Table 48: Application of Cloud-Based Services in Healthcare
Table 49: Leading LIMS Providers
Table 50: Key Suppliers of ELNs
Table 51: Leading Absorption, Distribution, Metabolism, Excretion and Toxicity Prediction Tools
Table 52: Drug R&D Process Overview
Table 53: Leading EHR Providers, 2018
Table 54: Medical Applications for Healthcare Professionals
Table 55: Pharmaceutical and Bioinformatic Partnerships and Alliances, 2015-2017
Table 56: North American Bioinformatics Market, by Country, Through 2023
Table 57: Leading Bioinformatics Companies in the U.S.
Table 58: Venture Capital Companies Most Active in the Biotech Sector, 2015
Table 59: U.S. Bioinformatics Market, by Application, Through 2023
Table 60: U.S. Bioinformatics Market, by Category, Through 2023
Table 61: Canadian Bioinformatics Market, by Category, Through 2023
Table 62: Leading Canadian Bioinformatics Companies
Table 63: Canadian Bioinformatics Market, by Application, Through 2023
Table 64: European Bioinformatics Market, by Country, Through 2023
Table 65: Leading European Bioinformatics Companies
Table 66: U.K. Bioinformatics Market, by Category, Through 2023
Table 67: U.K. Bioinformatics Market, by Application, Through 2023
Table 68: German Bioinformatics Market, by Category, Through 2023
Table 69: German Bioinformatics Market, by Application, Through 2023
Table 70: Swiss Bioinformatics Market, by Category, Through 2023
Table 71: Swiss Bioinformatics Market, by Application, Through 2023
Table 72: Asia-Pacific Bioinformatics Market, by Country, Through 2023
Table 73: Indian Bioinformatics Market, by Category, Through 2023
Table 74: Leading Indian Bioinformatics Companies
Table 75: Indian Bioinformatics Market, by Application, Through 2023
Table 76: Chinese Bioinformatics Market, by Category, Through 2023
Table 77: Chinese Bioinformatics Market, by Application, Through 2023
Table 78: Biomatters Ltd.: Product Portfolio
Table 79: Compugen Ltd.: Product Portfolio
Table 80: Dassault Systemes Biovia: Product Portfolio
Table 81: DNASTAR Inc.: Product Portfolio
Table 82: DNASTAR Inc.: Recent Developments, 2016
Table 83: Genedata AG: Product Portfolio
Table 84: Genedata AG: Recent Developments, 2017
Table 85: Geneva Bioinformatics (GeneBio) SA: Product Portfolio
Table 86: Genologics Lifesciences Software Inc.: Product Portfolio
Table 87: Genomatix Software GmbH: Product Portfolio
Table 88: GNS Healthcare Inc.: Product Portfolio
Table 89: GNS Healthcare Inc.: Recent Developments, 2015-2017
Table 90: GVK Biosciences Pvt. Ltd.: Product Portfolio
Table 91: GVK Biosciences Pvt. Ltd: Recent Developments, 2017
Table 92: Inte: Ligand Software Entwicklungs Und Consulting GmbH: Product Portfolio
Table 93: Illumina Inc.: Product Portfolio
Table 94: Illumina Inc.: Recent Developments, 2016-2017
Table 95: MacVector Inc.: Product Portfolio
Table 96: Molecular Connections Pvt. Ltd.: Product Portfolio
Table 97: Molecular Networks GmbH: Product Portfolio
Table 98: Nonlinear Dynamics Ltd.: Product Portfolio
Table 99: Ocimum Biosolutions Ltd.: Product Portfolio
Table 100: PerkinElmer Informatics Inc.: Product Portfolio
Table 101: Qlucore AB: Product Portfolio
Table 102: Qlucore AB: Product Portfolio
Table 103: Qlucore AB: Recent Developments, 2018
Table 104: Real Time Genomics Inc.: Product Portfolio
Table 105: Real Time Genomics Inc.: Recent Developments, 2016
Table 106: Smartgene Services SARL: Product Portfolio
Table 107: Strand Life Sciences: Product Portfolio
Table 108: Strand Life Sciences: Recent Developments, 2017 and 2018
Table 109: Syngene International: Product Portfolio
Table 110: Syngene International: Recent Developments, 2016-2019

List of Figures
Summary Figure: Overall Global Bioinformatics Market, by Region, 2017-2023
Figure 1: PDB Data Distribution, by Experimental Method and Molecular Type, 2017
Figure 2: RefSeq Accession Growth, 2016 and 2018
Figure 3: Relationship of Bioinformatics with Omic Technologies
Figure 4: Schematic Representation of Biology Systems and Translational Bioinformatics
Figure 5: Principles of Precision Medicine
Figure 6: Applications of Bioinformatics in Drug Development
Figure 7: Collaboration within the Bioinformatics Arena, by Country, Since 2016
Figure 8: Number of Drug Approvals, by FDA's CDER, 2008-2018*
Figure 9: Number of CDER's Annual Novel Drug Approvals, 2009-2018
Figure 10: The Four Dimensions of Big Data
Figure 11: Software Scalability of Big Data Bioinformatics
Figure 12: Software Validation of Big Data Bioinformatics
Figure 13: Percentage Distribution of Breast Cancer Diagnosis Among the U.S. Women, by Age Group, 2017
Figure 14: Top-Down Proteomic Approach
Figure 15: European Bioinformatics Institute Software Solutions
Figure 16: Evolution of Information Technology Infrastructure
Figure 17: Schematic Representation of Cloud Computing Services
Figure 18: Global Bioinformatics Market Share, by Sequencing Services and Platforms, 2017 and 2023
Figure 19: Global Bioinformatics Market, by Sequencing Services, 2017-2023
Figure 20: Global Bioinformatics Market, by Sequencing Platform, 2017-2023
Figure 21: Clinical Bioinformatics for Patients for Precision Health
Figure 22: Number of Therapeutic Drugs Developed Globally, by Disease Category, 2017
Figure 23: Classical and Digital Forensics with Respect to Bioinformatics
Figure 24: Drug Development Process
Figure 25: Phases in the Drug Discovery and Development Process
Figure 26: Phase Transition Success Rates and Likelihood of Approvals for All Modalities and Medicines, 2017
Figure 27: Steps in Drug Discovery
Figure 28: Information Systems within the Laboratory Architecture
Figure 29: Application of Bioinformatics in Clinical Trials
Figure 30: Key Areas of Research Utilizing Bioinformatics

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • 3rd Millennium Inc.
  • Dassault Systemes Biovia
  • Genomatix Software Gmbh
  • Illumina Inc.
  • Nonlinear Dynamics Ltd.
  • Qlucore Ab
  • MORE

Bioinformatics is the science of managing, analyzing, storing and merging biological data using advanced computing techniques. It requires a multidisciplinary approach and draws information from different disciplines to make vast, diverse and complex life science data more understandable and useful. The rapid growth in raw data generation and advances in IT software and infrastructure have enabled researchers to integrate disparate datasets in order to decipher complex biological processes and develop predictive models of disease, for the purposes of identifying and validating novel biomarkers and developing precision medicines.

Reasons for Doing This Study

Since scientists unraveled the blueprint of the human genome more than 10 years ago, they have been exploring new ways to utilize “omic” data to understand more complex diseases. Researchers are eager to analyze as many different types of data as possible to gain a better understanding of what is happening at the cellular and molecular levels. Service providers have developed new analytical tools and IT infrastructures to enable scientists to interrogate complex data sources and quickly and efficiently disseminate information for better decision-making to achieve this goal.

More recently, improvements in cloud computing capabilities, advances in data analysis software services and the growth of NGS technologies have helped to expand the evaluation of available datasets, allowing researchers to build systems biology models of various diseases.

Note: Product cover images may vary from those shown
5 of 5
  • 3rd Millennium Inc.
  • Biomatters Ltd. Geneious
  • Compugen Ltd.
  • Dassault Systemes Biovia
  • Dnastar, Inc.
  • Genedata Ag
  • Geneva Bioformatics (Genebio) Sa
  • Genologics Lifesciences Software Inc.
  • Genomatix Software Gmbh
  • GNS Healthcare Inc.
  • GVK Biosciences Pvt. Ltd.
  • Illumina Inc.
  • Inte Ligand Software Entwicklungs Und Consulting Gmbh
  • Macvector Inc.
  • Molecular Connections Pvt. Ltd.
  • Molecular Networks Gmbh
  • Nonlinear Dynamics Ltd.
  • Ocimum Biosolutions Ltd.
  • Perkinelmer Informatics Inc.
  • Personalis Inc.
  • Qlucore Ab
  • Real Time Genomics Inc.
  • Smartgene Services Sarl
  • Strand Life Sciences
  • Syngene International
Note: Product cover images may vary from those shown
Adroll
adroll